nodes	percent_of_prediction	percent_of_DWPC	metapath
Tinidazole—Chromaturia—Capecitabine—esophageal cancer	0.0381	0.0381	CcSEcCtD
Tinidazole—Drug hypersensitivity—Capecitabine—esophageal cancer	0.0337	0.0337	CcSEcCtD
Tinidazole—Oral candidiasis—Capecitabine—esophageal cancer	0.0214	0.0214	CcSEcCtD
Tinidazole—Haemoglobin decreased—Capecitabine—esophageal cancer	0.0198	0.0198	CcSEcCtD
Tinidazole—Body temperature increased—Carboplatin—esophageal cancer	0.0177	0.0177	CcSEcCtD
Tinidazole—Vaginal discharge—Methotrexate—esophageal cancer	0.0166	0.0166	CcSEcCtD
Tinidazole—Burning sensation—Methotrexate—esophageal cancer	0.0146	0.0146	CcSEcCtD
Tinidazole—Blood bilirubin increased—Capecitabine—esophageal cancer	0.0144	0.0144	CcSEcCtD
Tinidazole—Candida infection—Capecitabine—esophageal cancer	0.013	0.013	CcSEcCtD
Tinidazole—Cramp muscle—Cisplatin—esophageal cancer	0.0121	0.0121	CcSEcCtD
Tinidazole—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.0121	0.0121	CcSEcCtD
Tinidazole—Glossitis—Methotrexate—esophageal cancer	0.011	0.011	CcSEcCtD
Tinidazole—Thirst—Capecitabine—esophageal cancer	0.0104	0.0104	CcSEcCtD
Tinidazole—Arthritis—Capecitabine—esophageal cancer	0.0102	0.0102	CcSEcCtD
Tinidazole—Neuropathy peripheral—Cisplatin—esophageal cancer	0.0101	0.0101	CcSEcCtD
Tinidazole—Stomatitis—Cisplatin—esophageal cancer	0.0101	0.0101	CcSEcCtD
Tinidazole—Ataxia—Capecitabine—esophageal cancer	0.00928	0.00928	CcSEcCtD
Tinidazole—Coma—Methotrexate—esophageal cancer	0.00925	0.00925	CcSEcCtD
Tinidazole—Urinary tract disorder—Cisplatin—esophageal cancer	0.00915	0.00915	CcSEcCtD
Tinidazole—Urethral disorder—Cisplatin—esophageal cancer	0.00908	0.00908	CcSEcCtD
Tinidazole—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.00889	0.00889	CcSEcCtD
Tinidazole—Flushing—Cisplatin—esophageal cancer	0.00859	0.00859	CcSEcCtD
Tinidazole—Bronchospasm—Capecitabine—esophageal cancer	0.00839	0.00839	CcSEcCtD
Tinidazole—Immune system disorder—Cisplatin—esophageal cancer	0.00836	0.00836	CcSEcCtD
Tinidazole—Malnutrition—Cisplatin—esophageal cancer	0.00806	0.00806	CcSEcCtD
Tinidazole—Dysuria—Capecitabine—esophageal cancer	0.00797	0.00797	CcSEcCtD
Tinidazole—Neutropenia—Capecitabine—esophageal cancer	0.00797	0.00797	CcSEcCtD
Tinidazole—Flatulence—Cisplatin—esophageal cancer	0.00794	0.00794	CcSEcCtD
Tinidazole—Muscle spasms—Cisplatin—esophageal cancer	0.00775	0.00775	CcSEcCtD
Tinidazole—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.00754	0.00754	CcSEcCtD
Tinidazole—Ill-defined disorder—Cisplatin—esophageal cancer	0.00748	0.00748	CcSEcCtD
Tinidazole—Neuropathy peripheral—Capecitabine—esophageal cancer	0.00745	0.00745	CcSEcCtD
Tinidazole—Stomatitis—Capecitabine—esophageal cancer	0.00741	0.00741	CcSEcCtD
Tinidazole—Urinary tract infection—Capecitabine—esophageal cancer	0.00739	0.00739	CcSEcCtD
Tinidazole—Malaise—Cisplatin—esophageal cancer	0.00727	0.00727	CcSEcCtD
Tinidazole—Leukopenia—Cisplatin—esophageal cancer	0.00722	0.00722	CcSEcCtD
Tinidazole—Convulsion—Cisplatin—esophageal cancer	0.00698	0.00698	CcSEcCtD
Tinidazole—Ataxia—Methotrexate—esophageal cancer	0.00691	0.00691	CcSEcCtD
Tinidazole—Myalgia—Cisplatin—esophageal cancer	0.00686	0.00686	CcSEcCtD
Tinidazole—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00682	0.00682	CcSEcCtD
Tinidazole—Hypoaesthesia—Capecitabine—esophageal cancer	0.00679	0.00679	CcSEcCtD
Tinidazole—Discomfort—Cisplatin—esophageal cancer	0.00678	0.00678	CcSEcCtD
Tinidazole—Pharyngitis—Capecitabine—esophageal cancer	0.00678	0.00678	CcSEcCtD
Tinidazole—Urinary tract disorder—Capecitabine—esophageal cancer	0.00674	0.00674	CcSEcCtD
Tinidazole—Urethral disorder—Capecitabine—esophageal cancer	0.00669	0.00669	CcSEcCtD
Tinidazole—Erythema multiforme—Capecitabine—esophageal cancer	0.00645	0.00645	CcSEcCtD
Tinidazole—Nervous system disorder—Cisplatin—esophageal cancer	0.00645	0.00645	CcSEcCtD
Tinidazole—Thrombocytopenia—Cisplatin—esophageal cancer	0.00644	0.00644	CcSEcCtD
Tinidazole—Skin disorder—Cisplatin—esophageal cancer	0.00639	0.00639	CcSEcCtD
Tinidazole—Hyperhidrosis—Cisplatin—esophageal cancer	0.00636	0.00636	CcSEcCtD
Tinidazole—Flushing—Capecitabine—esophageal cancer	0.00634	0.00634	CcSEcCtD
Tinidazole—Anorexia—Cisplatin—esophageal cancer	0.00627	0.00627	CcSEcCtD
Tinidazole—Angiopathy—Capecitabine—esophageal cancer	0.00619	0.00619	CcSEcCtD
Tinidazole—Immune system disorder—Capecitabine—esophageal cancer	0.00617	0.00617	CcSEcCtD
Tinidazole—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00599	0.00599	CcSEcCtD
Tinidazole—Malnutrition—Capecitabine—esophageal cancer	0.00594	0.00594	CcSEcCtD
Tinidazole—Dysuria—Methotrexate—esophageal cancer	0.00594	0.00594	CcSEcCtD
Tinidazole—Neutropenia—Methotrexate—esophageal cancer	0.00594	0.00594	CcSEcCtD
Tinidazole—Paraesthesia—Cisplatin—esophageal cancer	0.00591	0.00591	CcSEcCtD
Tinidazole—Dyspnoea—Cisplatin—esophageal cancer	0.00587	0.00587	CcSEcCtD
Tinidazole—Flatulence—Capecitabine—esophageal cancer	0.00586	0.00586	CcSEcCtD
Tinidazole—Dysgeusia—Capecitabine—esophageal cancer	0.00582	0.00582	CcSEcCtD
Tinidazole—Decreased appetite—Cisplatin—esophageal cancer	0.00572	0.00572	CcSEcCtD
Tinidazole—Muscle spasms—Capecitabine—esophageal cancer	0.00571	0.00571	CcSEcCtD
Tinidazole—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00568	0.00568	CcSEcCtD
Tinidazole—Drowsiness—Methotrexate—esophageal cancer	0.00566	0.00566	CcSEcCtD
Tinidazole—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.00561	0.00561	CcSEcCtD
Tinidazole—Stomatitis—Methotrexate—esophageal cancer	0.00552	0.00552	CcSEcCtD
Tinidazole—Ill-defined disorder—Capecitabine—esophageal cancer	0.00551	0.00551	CcSEcCtD
Tinidazole—Sweating—Methotrexate—esophageal cancer	0.00543	0.00543	CcSEcCtD
Tinidazole—Feeling abnormal—Cisplatin—esophageal cancer	0.00542	0.00542	CcSEcCtD
Tinidazole—Malaise—Capecitabine—esophageal cancer	0.00536	0.00536	CcSEcCtD
Tinidazole—Vertigo—Capecitabine—esophageal cancer	0.00534	0.00534	CcSEcCtD
Tinidazole—Leukopenia—Capecitabine—esophageal cancer	0.00532	0.00532	CcSEcCtD
Tinidazole—Palpitations—Capecitabine—esophageal cancer	0.00525	0.00525	CcSEcCtD
Tinidazole—Body temperature increased—Cisplatin—esophageal cancer	0.0052	0.0052	CcSEcCtD
Tinidazole—Myalgia—Capecitabine—esophageal cancer	0.00506	0.00506	CcSEcCtD
Tinidazole—Arthralgia—Capecitabine—esophageal cancer	0.00506	0.00506	CcSEcCtD
Tinidazole—Pharyngitis—Methotrexate—esophageal cancer	0.00504	0.00504	CcSEcCtD
Tinidazole—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.00502	0.00502	CcSEcCtD
Tinidazole—Urinary tract disorder—Methotrexate—esophageal cancer	0.00502	0.00502	CcSEcCtD
Tinidazole—Discomfort—Capecitabine—esophageal cancer	0.005	0.005	CcSEcCtD
Tinidazole—Urethral disorder—Methotrexate—esophageal cancer	0.00498	0.00498	CcSEcCtD
Tinidazole—Confusional state—Capecitabine—esophageal cancer	0.00489	0.00489	CcSEcCtD
Tinidazole—Hypersensitivity—Cisplatin—esophageal cancer	0.00485	0.00485	CcSEcCtD
Tinidazole—Erythema multiforme—Methotrexate—esophageal cancer	0.0048	0.0048	CcSEcCtD
Tinidazole—Nervous system disorder—Capecitabine—esophageal cancer	0.00476	0.00476	CcSEcCtD
Tinidazole—Thrombocytopenia—Capecitabine—esophageal cancer	0.00475	0.00475	CcSEcCtD
Tinidazole—Asthenia—Cisplatin—esophageal cancer	0.00472	0.00472	CcSEcCtD
Tinidazole—Skin disorder—Capecitabine—esophageal cancer	0.00471	0.00471	CcSEcCtD
Tinidazole—Hyperhidrosis—Capecitabine—esophageal cancer	0.00469	0.00469	CcSEcCtD
Tinidazole—Anorexia—Capecitabine—esophageal cancer	0.00462	0.00462	CcSEcCtD
Tinidazole—Angiopathy—Methotrexate—esophageal cancer	0.00461	0.00461	CcSEcCtD
Tinidazole—Immune system disorder—Methotrexate—esophageal cancer	0.00459	0.00459	CcSEcCtD
Tinidazole—Diarrhoea—Cisplatin—esophageal cancer	0.0045	0.0045	CcSEcCtD
Tinidazole—Malnutrition—Methotrexate—esophageal cancer	0.00442	0.00442	CcSEcCtD
Tinidazole—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00442	0.00442	CcSEcCtD
Tinidazole—Insomnia—Capecitabine—esophageal cancer	0.00439	0.00439	CcSEcCtD
Tinidazole—Paraesthesia—Capecitabine—esophageal cancer	0.00435	0.00435	CcSEcCtD
Tinidazole—Dysgeusia—Methotrexate—esophageal cancer	0.00433	0.00433	CcSEcCtD
Tinidazole—Dyspnoea—Capecitabine—esophageal cancer	0.00432	0.00432	CcSEcCtD
Tinidazole—Dyspepsia—Capecitabine—esophageal cancer	0.00427	0.00427	CcSEcCtD
Tinidazole—Decreased appetite—Capecitabine—esophageal cancer	0.00422	0.00422	CcSEcCtD
Tinidazole—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00419	0.00419	CcSEcCtD
Tinidazole—Vomiting—Cisplatin—esophageal cancer	0.00418	0.00418	CcSEcCtD
Tinidazole—Fatigue—Capecitabine—esophageal cancer	0.00418	0.00418	CcSEcCtD
Tinidazole—Rash—Cisplatin—esophageal cancer	0.00415	0.00415	CcSEcCtD
Tinidazole—Constipation—Capecitabine—esophageal cancer	0.00415	0.00415	CcSEcCtD
Tinidazole—Dermatitis—Cisplatin—esophageal cancer	0.00414	0.00414	CcSEcCtD
Tinidazole—Ill-defined disorder—Methotrexate—esophageal cancer	0.0041	0.0041	CcSEcCtD
Tinidazole—Feeling abnormal—Capecitabine—esophageal cancer	0.004	0.004	CcSEcCtD
Tinidazole—Malaise—Methotrexate—esophageal cancer	0.00399	0.00399	CcSEcCtD
Tinidazole—Vertigo—Methotrexate—esophageal cancer	0.00397	0.00397	CcSEcCtD
Tinidazole—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00397	0.00397	CcSEcCtD
Tinidazole—Leukopenia—Methotrexate—esophageal cancer	0.00396	0.00396	CcSEcCtD
Tinidazole—Nausea—Cisplatin—esophageal cancer	0.00391	0.00391	CcSEcCtD
Tinidazole—Urticaria—Capecitabine—esophageal cancer	0.00385	0.00385	CcSEcCtD
Tinidazole—Abdominal pain—Capecitabine—esophageal cancer	0.00383	0.00383	CcSEcCtD
Tinidazole—Body temperature increased—Capecitabine—esophageal cancer	0.00383	0.00383	CcSEcCtD
Tinidazole—Convulsion—Methotrexate—esophageal cancer	0.00383	0.00383	CcSEcCtD
Tinidazole—Arthralgia—Methotrexate—esophageal cancer	0.00377	0.00377	CcSEcCtD
Tinidazole—Myalgia—Methotrexate—esophageal cancer	0.00377	0.00377	CcSEcCtD
Tinidazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.00374	0.00374	CcSEcCtD
Tinidazole—Discomfort—Methotrexate—esophageal cancer	0.00372	0.00372	CcSEcCtD
Tinidazole—Confusional state—Methotrexate—esophageal cancer	0.00364	0.00364	CcSEcCtD
Tinidazole—Hypersensitivity—Capecitabine—esophageal cancer	0.00357	0.00357	CcSEcCtD
Tinidazole—Nervous system disorder—Methotrexate—esophageal cancer	0.00354	0.00354	CcSEcCtD
Tinidazole—Thrombocytopenia—Methotrexate—esophageal cancer	0.00353	0.00353	CcSEcCtD
Tinidazole—Skin disorder—Methotrexate—esophageal cancer	0.00351	0.00351	CcSEcCtD
Tinidazole—Hyperhidrosis—Methotrexate—esophageal cancer	0.00349	0.00349	CcSEcCtD
Tinidazole—Asthenia—Capecitabine—esophageal cancer	0.00348	0.00348	CcSEcCtD
Tinidazole—Anorexia—Methotrexate—esophageal cancer	0.00344	0.00344	CcSEcCtD
Tinidazole—Pruritus—Capecitabine—esophageal cancer	0.00343	0.00343	CcSEcCtD
Tinidazole—Diarrhoea—Capecitabine—esophageal cancer	0.00332	0.00332	CcSEcCtD
Tinidazole—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.00329	0.00329	CcSEcCtD
Tinidazole—Insomnia—Methotrexate—esophageal cancer	0.00327	0.00327	CcSEcCtD
Tinidazole—Paraesthesia—Methotrexate—esophageal cancer	0.00324	0.00324	CcSEcCtD
Tinidazole—Dyspnoea—Methotrexate—esophageal cancer	0.00322	0.00322	CcSEcCtD
Tinidazole—Somnolence—Methotrexate—esophageal cancer	0.00321	0.00321	CcSEcCtD
Tinidazole—Dizziness—Capecitabine—esophageal cancer	0.00321	0.00321	CcSEcCtD
Tinidazole—Dyspepsia—Methotrexate—esophageal cancer	0.00318	0.00318	CcSEcCtD
Tinidazole—Decreased appetite—Methotrexate—esophageal cancer	0.00314	0.00314	CcSEcCtD
Tinidazole—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.00312	0.00312	CcSEcCtD
Tinidazole—Fatigue—Methotrexate—esophageal cancer	0.00311	0.00311	CcSEcCtD
Tinidazole—Vomiting—Capecitabine—esophageal cancer	0.00308	0.00308	CcSEcCtD
Tinidazole—Rash—Capecitabine—esophageal cancer	0.00306	0.00306	CcSEcCtD
Tinidazole—Dermatitis—Capecitabine—esophageal cancer	0.00306	0.00306	CcSEcCtD
Tinidazole—Headache—Capecitabine—esophageal cancer	0.00304	0.00304	CcSEcCtD
Tinidazole—Feeling abnormal—Methotrexate—esophageal cancer	0.00298	0.00298	CcSEcCtD
Tinidazole—Gastrointestinal pain—Methotrexate—esophageal cancer	0.00295	0.00295	CcSEcCtD
Tinidazole—Nausea—Capecitabine—esophageal cancer	0.00288	0.00288	CcSEcCtD
Tinidazole—Urticaria—Methotrexate—esophageal cancer	0.00287	0.00287	CcSEcCtD
Tinidazole—Abdominal pain—Methotrexate—esophageal cancer	0.00285	0.00285	CcSEcCtD
Tinidazole—Body temperature increased—Methotrexate—esophageal cancer	0.00285	0.00285	CcSEcCtD
Tinidazole—Hypersensitivity—Methotrexate—esophageal cancer	0.00266	0.00266	CcSEcCtD
Tinidazole—Asthenia—Methotrexate—esophageal cancer	0.00259	0.00259	CcSEcCtD
Tinidazole—Pruritus—Methotrexate—esophageal cancer	0.00255	0.00255	CcSEcCtD
Tinidazole—Diarrhoea—Methotrexate—esophageal cancer	0.00247	0.00247	CcSEcCtD
Tinidazole—Dizziness—Methotrexate—esophageal cancer	0.00239	0.00239	CcSEcCtD
Tinidazole—Vomiting—Methotrexate—esophageal cancer	0.0023	0.0023	CcSEcCtD
Tinidazole—Rash—Methotrexate—esophageal cancer	0.00228	0.00228	CcSEcCtD
Tinidazole—Dermatitis—Methotrexate—esophageal cancer	0.00227	0.00227	CcSEcCtD
Tinidazole—Headache—Methotrexate—esophageal cancer	0.00226	0.00226	CcSEcCtD
Tinidazole—Nausea—Methotrexate—esophageal cancer	0.00214	0.00214	CcSEcCtD
